Metronidazole-related neurotoxicity in a referral hospital
Author(s) -
Roshan Koul,
Saggere Muralikrishna Shasthry,
Archana Ramalingam,
Shiv Kumar Sarin
Publication year - 2020
Publication title -
indian journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 1998-3654
pISSN - 0019-5359
DOI - 10.25259/ijms_267_2020
Subject(s) - metronidazole , medicine , neurotoxicity , ataxia , drug , peripheral neuropathy , liver abscess , antibiotics , abscess , surgery , toxicity , pharmacology , psychiatry , microbiology and biotechnology , biology , diabetes mellitus , endocrinology
Objectives: Metronidazole is commonly used drug in almost all the fields of medicine. Commonly patients use medication for a shorter time than was prescribed, but in this report, the patients have used medication for long time based on ultrasound images. This study aims to assess metronidazole-related neurotoxicity at this hospital. Material and Methods: All the patients with diagnosis of amebic liver abscess, who developed neurotoxicity with metronidazole, were evaluated retrospectively. Results: Ten patients with metronidazole neurotoxicity were seen from April 2017 to March 2019. All ten had peripheral neuropathy; one each had in addition cerebellar ataxia and new onset seizures. Conclusion: A preventable toxic effect with metronidazole has to be recognized early during drug therapy for hepatic amebic abscesses. A dose adjustment during therapy helps in preventing this neurotoxicity. The patients have to be educated that metronidazole should not be continued on ultrasound images.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom